Baseline characteristics of the patients
| Patient characteristics . | Sequential (n = 118) . | Alternating (n = 115) . |
|---|---|---|
| Age, y | 75 (65-89) | 73 (66-87) |
| Age ≥75 y | 65 (55%) | 52 (45%) |
| M protein | ||
| IgG | 52 (44%) | 54 (47%) |
| IgA | 32 (27%) | 35 (30%) |
| Light chain | 14 (12%) | 10 (9%) |
| ISS stage | ||
| I | 21 (18%) | 23 (20%) |
| II | 44 (37%) | 49 (43%) |
| III | 35 (30%) | 29 (25%) |
| Plasma cell bone marrow infiltration >35% | 50 (43%) | 50 (44%) |
| High risk [t(4;14), t(14;16), del17p] by FISH | 19 (16%) | 13 (11%) |
| Patient characteristics . | Sequential (n = 118) . | Alternating (n = 115) . |
|---|---|---|
| Age, y | 75 (65-89) | 73 (66-87) |
| Age ≥75 y | 65 (55%) | 52 (45%) |
| M protein | ||
| IgG | 52 (44%) | 54 (47%) |
| IgA | 32 (27%) | 35 (30%) |
| Light chain | 14 (12%) | 10 (9%) |
| ISS stage | ||
| I | 21 (18%) | 23 (20%) |
| II | 44 (37%) | 49 (43%) |
| III | 35 (30%) | 29 (25%) |
| Plasma cell bone marrow infiltration >35% | 50 (43%) | 50 (44%) |
| High risk [t(4;14), t(14;16), del17p] by FISH | 19 (16%) | 13 (11%) |
Data are given as number (percentage) or median (interquartile range).
Ig, immunoglobulin; ISS, International Staging System.